Cardiac myxoma and its implications for cardioembolic stroke

Area of Science:

• Cardiology
• Neurology
• Oncology

Background:

• Cardiac myxoma (CM) is the most frequent primary cardiac tumor.
• CM is a significant source of cardioembolic stroke, often presenting with neurological complications.
• Understanding CM-related ischemic stroke (CM-IS) mechanisms and risk factors is crucial.

Purpose of the Study:

• To review current knowledge on cardiac myxoma-related ischemic stroke (CM-IS).
• To identify key risk factors contributing to embolic events in CM patients.
• To discuss current treatment strategies and highlight areas for future research.

Main Methods:

• Comprehensive literature review of studies on cardiac myxoma and ischemic stroke.
• Analysis of clinical manifestations, diagnostic imaging, and laboratory findings.
• Evaluation of surgical and medical management approaches for CM-IS.

Main Results:

• CM-IS can arise from tumor debris embolism or metastatic infiltration.
• Risk factors for embolic complications from CM are debated but critical to identify.
• Histopathological examination is essential for definitive diagnosis.
• Surgical resection is the primary treatment, but timing and approach require further clarification.

Conclusions:

• Individualized management protocols are necessary for CM-IS patients.
• Further research is needed to refine risk stratification and treatment optimization.
• Improved understanding and management can lead to better outcomes for CM-IS.